Molbio Diagnostics gets DCGI nod for Nipah virus testing
Nipah virus testing can now be performed rapidly on Truenat, a real-time PCR platform, on demand, the Goa-based firm said. This will result in early and fast diagnosis for effective management of the disease and containment of the spread of Nipah virus, it added. (Source: The Economic Times)
Source: The Economic Times - September 8, 2021 Category: Consumer Health News Source Type: news

COVID-19 may not impair lung function in young adults, research shows
However, such patients showed slightly lower measurements for the amount of air they could exhale forcibly in one second - known as forced expiratory air volume in one second (FEV1), which is one of the measures of lung function. (Source: The Economic Times)
Source: The Economic Times - September 8, 2021 Category: Consumer Health News Source Type: news

How to check Vijaya Diagnostics Centre IPO allotment status
The initial public offer of Vijaya Diagnostics Centre was subscribed 4.54 times on the final day of subscription on Friday. The retail portion was subscribed by 1.09 times; so it is expected that all the retail investors may get the allotment of Vijaya Diagnostic IPO. (Source: The Economic Times)
Source: The Economic Times - September 7, 2021 Category: Consumer Health News Source Type: news

Metabolic changes in plasma, immune cells associated with COVID-19 severity: Study
The researchers collected 374 blood samples -- two draws per patient during the first week after being diagnosed with SARS-CoV-2 infection -- and analyzed their plasma and single immune cells. The analysis included 1,387 genes involved in metabolic pathways and 1,050 plasma metabolites. (Source: The Economic Times)
Source: The Economic Times - September 7, 2021 Category: Consumer Health News Source Type: news

Increased infectivity, ability to escape immunity drove Delta variant: Study
The B.1.617.2 or Delta variant was first observed in India in late 2020. It has since spread around the globe. (Source: The Economic Times)
Source: The Economic Times - September 7, 2021 Category: Consumer Health News Source Type: news

Over 16,000 COVID-19 samples sent for whole genome sequencing in July, August: Centre
Genomic surveillance of SARS-COV-2 is crucial to determine incidence and prevalence of the variants of concern. "It is clarified that the number of sequences, as quoted in the report, seems to be taken from Indian COVID19 Genome Surveillance portal," the ministry said. (Source: The Economic Times)
Source: The Economic Times - September 6, 2021 Category: Consumer Health News Source Type: news

Apollo hospital unit claims completion of 100 robotic cardiac surgeries
"The establishment of a robot-assisted cardiac surgery programme requires a tremendous amount of dedication and preparation, and we are proud to be India's first hospital to complete 100 robotic cardiac surgeries since the program's inception in late 2019," claimed Sathyaki Nambala, senior consultant, cardiothoracic and vascular surgeon, at the hospital. (Source: The Economic Times)
Source: The Economic Times - September 6, 2021 Category: Consumer Health News Source Type: news

View: Making sense of Covid data isn ’t easy
Whether you Google these questions, or phone your mother to see what she thinks, the answers you receive are bound to be at best varied and at worst contradictory or even wrong. (Source: The Economic Times)
Source: The Economic Times - September 6, 2021 Category: Consumer Health News Source Type: news

Govt move to distribute Ayush prophylactic medicines will help immunity-boosted lifestyle: PHDCCI
In the next one year, the immunity booster medicines and the written guidelines to combat COVID-19 will be distributed to 75 lakh people across the country with a special focus on the geriatric (Source: The Economic Times)
Source: The Economic Times - September 5, 2021 Category: Consumer Health News Source Type: news

SRL Diagnostics allocates Rs 300-500 cr for expansion by FY23-end
"We have allocated Rs 300-500 crore for expansion needs up to FY23-end... Since we already have a strong laboratory network, we will be adding only about 25-30 labs during this period. We will also be adding 1,500 collection centres in this time," SRL Diagnostics CEO Anand K told PTI. (Source: The Economic Times)
Source: The Economic Times - September 5, 2021 Category: Consumer Health News Source Type: news

Take advantage of Rs 50,000-cr loan guarantee scheme: MoS Finance Karad to healthcare sector
Under the scheme, healthcare service providers can avail loans up to Rs 100 crore at an attractive interest rate of 7.95 per cent per annum, to develop and upgrade both greenfield (fresh) and brownfield (existing) projects in other than eight metro cities. (Source: The Economic Times)
Source: The Economic Times - September 5, 2021 Category: Consumer Health News Source Type: news

CDC studies call for vaccinating schoolkids, staff
One study released on Saturday found that the virus could spread rapidly among unvaccinated children in indoor contact with unvaccinated teachers. (Source: The Economic Times)
Source: The Economic Times - September 5, 2021 Category: Consumer Health News Source Type: news

E-cigarettes: misconceptions about their dangers may be preventing people from quitting smoking
In recent surveys, nearly half of US and a third of British respondents considered nicotine e-cigarettes to be as harmful as cigarettes, if not more harmful. (Source: The Economic Times)
Source: The Economic Times - September 3, 2021 Category: Consumer Health News Source Type: news

India in need of 4.3 million more nurses by 2024 to meet WHO norms: nurses bodies
With 1.7 nurses per 1,000 population, India falls short of the WHO recommended rate of 3 nurses per 1,000 population, they said, noting that the country is in need of 4.3 million more nurses by 2024 to meet WHO norms. (Source: The Economic Times)
Source: The Economic Times - September 2, 2021 Category: Consumer Health News Source Type: news

India's interests come before vaccine exports, says health ministry
"Every country works with an aim of keeping its people, economy and social system safe," Rajesh Bhushan told a weekly news conference. (Source: The Economic Times)
Source: The Economic Times - September 2, 2021 Category: Consumer Health News Source Type: news

Why mental health startups haven't yet taken off in India
Despite the magnitude of the problem, risk money has largely eluded mental health startups in India, a sector that receives limited public money. According to data sourced from industry tracker Traxcn, Indian startups in the sector raised $20 million combined between 2016 -2020. (Source: The Economic Times)
Source: The Economic Times - September 2, 2021 Category: Consumer Health News Source Type: news

DCGI gives nod for phase 2/3 trials of Biological E's Covid vaccine on those aged between 5 & 18
The phase 2 and 3 clinical trials have be conducted as per approved protocol titled 'A Prospective, Randomised, Double-blind, Placebo controlled, Phase-2/3 Study to Evaluate Safety, Reactogenicity, Tolerability and Immunogenicity of Corbevax Vaccine in Children and Adolescents', a source said. (Source: The Economic Times)
Source: The Economic Times - September 2, 2021 Category: Consumer Health News Source Type: news

COVID-19 vaccines effective at reducing severe illness, hospitalisation: Lancet study
"We are at a critical point in the pandemic as we see cases rising worldwide due to the Delta variant. Breakthrough infections are expected and don't diminish the fact that these vaccines are doing exactly what they were designed to do -- save lives and prevent serious illness," said study co-lead author Claire Steves of King's College London, UK. (Source: The Economic Times)
Source: The Economic Times - September 2, 2021 Category: Consumer Health News Source Type: news

Covid variant C.1.2 experimenting with itself to know our system: IMA Kerala
(Source: The Economic Times)
Source: The Economic Times - September 1, 2021 Category: Consumer Health News Source Type: news

No of COVID-19 breakthrough infections in India within expected numbers: INSACOG
It said based on high stringency reclassification by INSACOG, the total number of Delta sub-lineages - Delta Plus AY.1 to AY.12 - in India are only 856 out of all samples analysed, which is much less than what is reported on some global websites. (Source: The Economic Times)
Source: The Economic Times - September 1, 2021 Category: Consumer Health News Source Type: news

Vijaya Diagnostics Centre IPO to open tomorrow: Should you apply?
The grey market premium shows the market is also not that enthusiastic about the issue. Grey market premium for Vijaya Diagnostics is at Rs 30, which is 5.6 per cent of IPO price. It suggests there may not be any big listing gains. (Source: The Economic Times)
Source: The Economic Times - August 31, 2021 Category: Consumer Health News Source Type: news

Breakthrough COVID-19 infections found in 25 per cent healthcare staff in Delhi: Study
Most infections were unrecognised. The Delta- variant thus causes frequent unrecognised breakthrough infections in adequately immunised subjects, reducing any herd-effect of immunity, and requiring reinstatement of preventive measures such as masking, the paper said. (Source: The Economic Times)
Source: The Economic Times - August 31, 2021 Category: Consumer Health News Source Type: news

What happens when the COVID-19 vaccines enter the body – a road map for kids and grown-ups
The most important thing to understand about vaccines is that they teach your body how to gear up to fight an infection, without your body having to deal with the infection itself. In this way, vaccines help your body be prepared for invasions by germs that could otherwise make you very sick. (Source: The Economic Times)
Source: The Economic Times - August 31, 2021 Category: Consumer Health News Source Type: news

Vaccination booster: How many more months will it take to fully vaccinate India's entire adult population?
​​While achieving this blistering pace every day may be still some time away, August, at an average 5.74 million daily shots, has proved to be the best month yet for vaccine delivery. (Source: The Economic Times)
Source: The Economic Times - August 30, 2021 Category: Consumer Health News Source Type: news

Covaxin supply set to rise as new plant goes on stream
The Ankleshwar plant, constructed in 2020, has a manufacturing capacity of more than 10 million doses per month, and supplies will be available for the vaccination programme next month, the minister said. The company however did not disclose the number of doses that have been released. It had earlier announced that it plans to produce an additional 200 million doses of Covaxin at the wholly-owned unit. (Source: The Economic Times)
Source: The Economic Times - August 30, 2021 Category: Consumer Health News Source Type: news

Recruitment for Covovax trials among children starts
Indigenously developed Zydus Cadila's needle-free Covid-19 vaccine ZyCoV-D has received emergency use authorisation from the drug regulator, making it the first vaccine to be administered in the age group of 12-18 years in the country. (Source: The Economic Times)
Source: The Economic Times - August 30, 2021 Category: Consumer Health News Source Type: news

List of countries with highest Covid-19 vaccine numbers
India has administered more than 630 million Covid-19 vaccine doses so far, numbers released last weekend by the Union Health Ministry showed. Let's take a look at the figures in some of the other countries. (Source: The Economic Times)
Source: The Economic Times - August 30, 2021 Category: Consumer Health News Source Type: news

Covaxin single-dose for survivor may be as effective as both for uninfected
According to a pilot study by ICMR (Indian Council for Medical Research) a single dose of Bharat Biotech ’s Covaxin in people who have been infected with the virus has a response that is similar to that provided by two doses of the vaccine in those without any history of the infection. (Source: The Economic Times)
Source: The Economic Times - August 29, 2021 Category: Consumer Health News Source Type: news

Record 10.2 million Covid-19 shots given in a day
"Record vaccination numbers today! Crossing 1 crore is a momentous feat. Kudos to those getting vaccinated and those making the vaccination drive a success," Prime Minister Narendra Modi tweeted. (Source: The Economic Times)
Source: The Economic Times - August 28, 2021 Category: Consumer Health News Source Type: news

Covaxin single dose to covid survivor equivalent to two doses for non-infected: ICMR study
(Source: The Economic Times)
Source: The Economic Times - August 28, 2021 Category: Consumer Health News Source Type: news

Risk of hospitalisations higher with Delta variant: UK study
The study, carried out by Public Health England (PHE) and Cambridge University and published in ‘The Lancet' journal on Friday, is the first of its kind to compare the hospitalisation risk of the two variants and highlights the need for people to be fully vaccinated. (Source: The Economic Times)
Source: The Economic Times - August 28, 2021 Category: Consumer Health News Source Type: news

If previously COVID-19 infected, single Covaxin dose draws same antibody response as two doses
"If our preliminary findings are confirmed in large population studies, a single dose of BBV152 vaccine may be recommended to previously confirmed SARS-CoV-2 infected individuals so that the naive individuals could attain the larger benefit of a limited vaccine supply," it said. (Source: The Economic Times)
Source: The Economic Times - August 28, 2021 Category: Consumer Health News Source Type: news

COVID-19 bigger blood clot threat than vaccines, UK study finds
The findings showed although there was an increased risk of having a blood clot after having the first doses of either vaccine, it was much greater in someone who had tested positive for COVID-19 caused by the SARS-CoV-2 virus. (Source: The Economic Times)
Source: The Economic Times - August 27, 2021 Category: Consumer Health News Source Type: news

Half of hospitalised Covid patients have persisting symptoms after a year: Lancet study
The research on 1,276 patients from Wuhan, China, shows that around one in three people still experienced shortness of breath after 12 months, while lung impairments persisted in some patients, especially those who had experienced the most severe illness with COVID-19. (Source: The Economic Times)
Source: The Economic Times - August 27, 2021 Category: Consumer Health News Source Type: news

Vaccines could affect how the coronavirus evolves - but that's no reason to skip your shot
In 2015, my collaborators and I published a scientific paper about a chicken virus you have likely never heard of. At the time, it got some media attention and has been cited by other scientists in the years since. (Source: The Economic Times)
Source: The Economic Times - August 27, 2021 Category: Consumer Health News Source Type: news

Do I need a booster shot if I got the Johnson & Johnson COVID-19 vaccine? A virologist answers 5 questions
Clinical trial data showed that four weeks after vaccination, the Johnson& Johnson vaccine was 66.3% effective at preventing COVID-19 infection. The initial studies also showed that it was 85% effective at preventing severe disease and 100% effective at protecting against COVID-related hospitalization. (Source: The Economic Times)
Source: The Economic Times - August 27, 2021 Category: Consumer Health News Source Type: news

Half of COVID patients had lingering symptoms one year later
While many symptoms improved over time and many of the 479 people who had been employed when they got COVID had returned to their original job, 49% of patients still had at least one health problem. (Source: The Economic Times)
Source: The Economic Times - August 27, 2021 Category: Consumer Health News Source Type: news

Pregnant or worried about infertility? Get vaccinated against COVID-19
It is completely understandable to have questions about how a new vaccine might affect reproductive health. But the science is clear that getting vaccinated does not put women at risk for infertility. (Source: The Economic Times)
Source: The Economic Times - August 26, 2021 Category: Consumer Health News Source Type: news

Preparing for another wave: Delhi gets a COVID-19 rapid response centre at Rajiv Gandhi hospital
Delhi health minister Satyendar Jain on Monday inaugurated a one-of-its kind coronavirus rapid response centre at Delhi's Rajiv Gandhi Super Specialty Hospital. (Source: The Economic Times)
Source: The Economic Times - August 26, 2021 Category: Consumer Health News Source Type: news

Covishield dose gap being reconsidered again: Government Sources
(Source: The Economic Times)
Source: The Economic Times - August 26, 2021 Category: Consumer Health News Source Type: news

Will three-dose Covid vaccine give Cadila Healthcare a booster shot?
Analysts do see a lift to its sales, even as some of them are not factoring in sales beyond FY23 amid uncertainty over booster shots. The pricing of the dose would influence the likely gains for Cadila, with initial brokerage estimates pegging the blended price in Rs 150-320 (per dose) range. (Source: The Economic Times)
Source: The Economic Times - August 24, 2021 Category: Consumer Health News Source Type: news

Pfizer-BioNTech Covid vaccine wins landmark US approval
Around 52% of the country is fully vaccinated, but health authorities have hit a wall of vaccine hesitant people, impeding the national campaign. (Source: The Economic Times)
Source: The Economic Times - August 24, 2021 Category: Consumer Health News Source Type: news

FDA gives full approval of Pfizer vaccine, a first for a COVID-19 shot
(Source: The Economic Times)
Source: The Economic Times - August 24, 2021 Category: Consumer Health News Source Type: news

Acute COVID is unlikely in children during possible 3rd wave: Ganga Ram Hospital
(Source: The Economic Times)
Source: The Economic Times - August 24, 2021 Category: Consumer Health News Source Type: news

Prone positioning can prevent need for ventilation in COVID-19 patients: Lancet study
The findings are from a trial conducted in medical centres in the US, Mexico, France, Canada, Ireland, and Spain on severely ill patients with COVD-19 between April 2020 and January 2021. (Source: The Economic Times)
Source: The Economic Times - August 24, 2021 Category: Consumer Health News Source Type: news

India working on developing Pan-Corona shot: Dr Renu Swarup
While speaking to in an exclusive interview, she said, "We are already preparing for the future, for a new vaccine, which is Pan-Corona. So that if there is any other such virus that comes in or any other such variant that comes in, the vaccine would be able to respond to all of them." (Source: The Economic Times)
Source: The Economic Times - August 23, 2021 Category: Consumer Health News Source Type: news

COVID vaccine: Adolescents likely to get 'ZyCoV-D' after four weeks
(Source: The Economic Times)
Source: The Economic Times - August 23, 2021 Category: Consumer Health News Source Type: news

How will Covid-19 variant Delta evolve? Here's what the theory tells us
Evolution is a result of random mutations (or errors) in the viral genome when it replicates. A few of these random mutations will be good for the virus, conferring some advantage. Copies of these advantageous genes are more likely to survive into the next generation, via the process of natural selection. (Source: The Economic Times)
Source: The Economic Times - August 23, 2021 Category: Consumer Health News Source Type: news

Healthcare facilities provided to 3 states to help fight potential 3rd COVID wave: IBM
The healthcare facilities have been provided as part of IBM India's corporate social responsibility (CSR) initiative in partnership with the Nasscom Foundation. (Source: The Economic Times)
Source: The Economic Times - August 22, 2021 Category: Consumer Health News Source Type: news

Delta dents vaccination edge: A look at the studies and what they mean for India
According to the latest studies, vaccines are not as effective against the Delta variant of SARS-CoV-2 as they are against the original coronavirus. The US has already announced a booster dose to make up for the lower effectiveness against the variant ravaging the world. Teena Thacker looks at the studies and what they mean for India. (Source: The Economic Times)
Source: The Economic Times - August 22, 2021 Category: Consumer Health News Source Type: news